Published in

Elsevier, European Journal of Cancer, (159), p. 174-181, 2021

DOI: 10.1016/j.ejca.2021.09.039

Links

Tools

Export citation

Search in Google Scholar

First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

Journal article published in 2021 by Margarita Majem ORCID, Ivanna Sullivan, Santiago Viteri, Guillermo López-Vivanco ORCID, Manuel Cobo, José M. Sánchez, Jorge García-González ORCID, Javier Garde, Miguel Sampayo, Griselda Martrat, Andrea Malfettone, Niki Karachaliou, Miguel A. Molina-Vila ORCID, Rafael Rosell
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO